Phaladel SA
4.0 FTEThe score of Phaladel shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -63 % Total assets -46 % Headcount (avg FTE) +54 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Phaladel's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 2,481 € | ||||
| Equity | 437,036 € | ||||
| Cash | 66,728 € | ||||
| EBITDA | 39,241 € | ||||
| Total assets | 694,145 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 02 Jul 2026
- Year ended 31 Dec 2024filed on 04 Aug 2025
- Year ended 31 Dec 2023filed on 12 Sep 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Phaladel's financial analysis
- Solvency63.0%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Phaladel
Phaladel's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0417.176.313
- VAT number
- BE0417176313
- Peppol
- Registered · 0208:0417176313 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 10 May 1977
- Registered office
- 7090 Braine-le-Comte
- Size
- Micro · 4.0 FTE
- Latest accounts
- 2025 · filed on 02 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Phaladel (SA) has been based in Braine-le-Comte since 1977, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 2,481 € and equity of 437,036 €; its revenue is not published. With 4.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 63.0%, above the median of its sector (41.5%).
Companies similar to Phaladel
Companies in the same business, of comparable size and area, outside its group.
- Apotheek De Wachter Retail sale of pharmaceutical products Lede · balance sheet 694,615 €
- Pharmacie Risselin Retail sale of pharmaceutical products Péruwelz · balance sheet 693,499 €
- Dierick & Verleyen Mouscron Retail sale of pharmaceutical products Mouscron · balance sheet 692,455 €
- Pharmacare Retail sale of pharmaceutical products Herent · balance sheet 695,856 €
- Apoteek Ginderbuiten Retail sale of pharmaceutical products Mol · balance sheet 692,197 €
- 3-Folia Retail sale of pharmaceutical products Ghent · balance sheet 696,291 €
- NS Pharma Retail sale of pharmaceutical products Sambreville · balance sheet 691,656 €
- Aubelpharma Retail sale of pharmaceutical products Aubel · balance sheet 696,844 €
Frequently asked questions about Phaladel
What is the revenue of Phaladel?
Phaladel files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Phaladel?
In Belgium, the VAT number is the company number prefixed with BE: BE0417176313 for Phaladel, if the company is VAT-registered. Its company number (CBE) is 0417.176.313.
Where is the registered office of Phaladel?
According to the CBE register, the registered office of Phaladel is in 7090 Braine-le-Comte.
What is the equity of Phaladel?
At the close of the 2025 financial year, the equity of Phaladel amounts to 437,036 €, a solvency of 63.0% of total assets.
How many people work at Phaladel?
4.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Phaladel?
The register lists 3 active mandates at Phaladel. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Phaladel
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →